Preview complete
The prescreener preview is complete. You may now close the preview.
AI-powered
Identification of Serum and Urine Biomarkers of Type 1 Diabetes
Study on Biomarkers for Predicting Type 1 Diabetes Risk
Recruiting
40 years or below
All
Phase
N/A
1 Location
Brief description of study.
The purpose of this study is to identify biomarkers (small molecules in the blood) that can predict those people at risk of developing Type 1 diabetes.
Detailed description of study
The purpose of this study is to develop and validate biomarkers that predict T1D disease risk and document disease progression based on blood or urine indicators of beta cell stress and death in emerging and establish T1D.
Participants will be compensated for their participation.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: healthy,type i diabetes,type 1 diabetes,diabetes,diabetic
-
Age: 40 years or below
-
Gender: All
Inclusion Criteria
Healthy adult or child without diabetes or new type 1 diabetic within 7 days of diagnosis by a physician.
Exclusion Criteria
Pregnant
Current smoker
Psychiatric impairment or current use of anti-psychotic medication
Chronic illness known to affect glucose metabolism or taking medications known to affect glucose metabolism
Healthy adult or child without diabetes or new type 1 diabetic within 7 days of diagnosis by a physician.
Exclusion Criteria
Pregnant
Current smoker
Psychiatric impairment or current use of anti-psychotic medication
Chronic illness known to affect glucose metabolism or taking medications known to affect glucose metabolism
Updated on
19 Feb 2024.
Study ID: 1411938757
This study investigates biomarkers, which are small molecules found in the blood, to understand who might be at risk for developing Type 1 diabetes. The purpose is to find and test these biomarkers to see if they can show how the disease starts and progresses, using signs from blood or urine related to the health of beta cells, which are important for insulin production.
Participants in the study will undergo procedures to collect blood and urine samples. These samples will be analyzed to look for indicators of beta cell stress and death, which can provide information about the risk and progression of Type 1 diabetes.
- Who can participate: The study is open to healthy adults or children who do not have diabetes, or those newly diagnosed with Type 1 diabetes within the last 7 days.
- Study details: Participants will provide blood and urine samples for analysis. These samples will be used to identify biomarkers that indicate stress and damage to beta cells, which are crucial for insulin production.
Pre-Screener
